Balanced charging of each cell in a battery pack is critical to meeting system requirements and maximising lifespan, while ...

Bristol Myers Squibb has expanded its push into radiopharmaceuticals by licensing a prostate cancer therapy developed by Swiss biotech Philochem in a deal that includes an upfront payment of $350 ...

Bristol Myers Squibb has expanded its direct-to-consumer (DTC) sales of medicines in the US with the addition of its psoriasis therapy Sotyktu. All of the DTC channels offer discounts for people ...

If you miss the days when you used Basic on your classic computer or wrote embedded software with a Basic Stamp, then maybe dust off your Arduino UNO or any similar AVR board and try nanoBASIC_UNO ...

The former leaders of SpringWorks Therapeutics are back with a new biotech venture that is already buzzing from a $300 million series A. Beeline Medicines flew out of stealth today with its stores ...

When [OGS Mechanics] got a Mercedes EQC 300 battery-electric car in for repair, it was found to have a bit of a weird issue: ...

The impending merger between Bristol-Myers Squibb (BMS) and Medarex marks the end of an era. Medarex is one of the last independent public biotech companies that built their businesses around ...

B.M.S. Institute of Technology and Management (BMSIT), Bengaluru Brochure Yes, it offers a 2 year MBA course. Is BMSIT Bengaluru accredited by NAAC? Yes, it is accredited with an ‘A’ grade by NAAC.

・Layoff filings show UnitedHealth’s Optum units planning the largest set of early-2026 job reductions among major healthcare employers. ・Merck, Bristol Myers Squibb, and Novartis are pushing through ...

Leading Beeline Medicines’ pipeline is afimetoran, which is in Phase 2 development for systemic lupus erythematosus with data expected later this year. In July 2025, Bristol Myers Squibb announced ...